A snippet from one of press release slides on Q1 14 by Dr Reddys:
Global Generics : US
Market Share – Key Products
•Fondaparinux market share 29% (May-13) from 27%(Mar-13)
•Retaining share in other key products- tacrolimus, lansoprazole , ziprazidone and omeprazole DR (Source : IMS volumes)
•New product launch – Zoledronic acid market share ~30% for both the variants individually
•Finasteride (FTF) market Share: 81% (Source : IMS Rx)
reddys q1 results, page-2
Add TSN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable